File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

TitleClonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Authors
Issue Date2016
PublisherPublic Library of Science. The Journal's web site is located at http://medicine.plosjournals.org/perlserv/?request=index-html&issn=1549-1676
Citation
PLoS Medicine, 2016, v. 13 n. 12, p. e1002136:1-23 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/236420
ISSN
2011 Impact Factor: 16.269
2015 SCImago Journal Rankings: 5.667
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorGoh, G-
dc.contributor.authorSchmid, R-
dc.contributor.authorGuiver, K-
dc.contributor.authorArpornwirat, W-
dc.contributor.authorChitapanarux, I-
dc.contributor.authorGanju, V-
dc.contributor.authorIm, SA-
dc.contributor.authorKim, SB-
dc.contributor.authorDechaphunkul, A-
dc.contributor.authorManeechavakajorn, J-
dc.contributor.authorSpector, N-
dc.contributor.authorYau, TCC-
dc.contributor.authorAfrit, M-
dc.contributor.authorBen Ahmed, S-
dc.contributor.authorJohnston, SR-
dc.contributor.authorGibson, N-
dc.contributor.authorUttenreuther-Fischer, M-
dc.contributor.authorSwanton, C-
dc.date.accessioned2016-11-25T00:53:08Z-
dc.date.available2016-11-25T00:53:08Z-
dc.date.issued2016-
dc.identifier.citationPLoS Medicine, 2016, v. 13 n. 12, p. e1002136:1-23-
dc.identifier.issn1549-1277-
dc.identifier.urihttp://hdl.handle.net/10722/236420-
dc.languageeng-
dc.publisherPublic Library of Science. The Journal's web site is located at http://medicine.plosjournals.org/perlserv/?request=index-html&issn=1549-1676-
dc.relation.ispartofPLoS Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleClonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1371/journal.pmed.1002136-
dc.identifier.hkuros270527-
dc.identifier.volume13-
dc.identifier.issue12-
dc.identifier.spagee1002136:1-
dc.identifier.epage23-
dc.identifier.isiWOS:000392142400001-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats